Basit öğe kaydını göster

dc.contributor.authorHERGENÇ, Gülay
dc.contributor.authorCan, Günay
dc.contributor.authorNARTOP, Filiz
dc.contributor.authorUGUR, Murat
dc.contributor.authorONAT, Altan
dc.date.accessioned2021-03-05T13:11:13Z
dc.date.available2021-03-05T13:11:13Z
dc.date.issued2011
dc.identifier.citationONAT A., HERGENÇ G., Can G., UGUR M., NARTOP F., "Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk", CLINICAL CHEMISTRY AND LABORATORY MEDICINE, cilt.49, ss.1349-1357, 2011
dc.identifier.issn1434-6621
dc.identifier.otherav_b0fff58f-99c2-4d8a-a42b-1b97b93f0bd3
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/117944
dc.identifier.urihttps://doi.org/10.1515/cclm.2011.110
dc.description.abstractBackground: The clinical relevance of serum lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in populations prone to cardiometabolic risk needs exploration. We determined major covariates of Lp-PLA(2) mass, and its associations with cardiometabolic disorders.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titleDual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk
dc.typeMakale
dc.relation.journalCLINICAL CHEMISTRY AND LABORATORY MEDICINE
dc.contributor.departmentTurkish Heart Foundation , ,
dc.identifier.volume49
dc.identifier.issue8
dc.identifier.startpage1349
dc.identifier.endpage1357
dc.contributor.firstauthorID90764


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster